-
1
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
2
-
-
0026620239
-
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
-
DOI 10.1016/0090-8258(92)90100-W
-
Hoskins WJ, Bundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 1992;47:159-66. (Pubitemid 23001322)
-
(1992)
Gynecologic Oncology
, vol.47
, Issue.2
, pp. 159-166
-
-
Hoskins, W.J.1
Bundy, B.N.2
Thigpen, J.T.3
Omura, G.A.4
-
3
-
-
0036200879
-
Survival among U.S. Women with invasive epithelial ovarian cancer
-
DOI 10.1006/gyno.2001.6536
-
McGuire V, Jesser CA, Whittemore AS. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol 2002;84:399-403. (Pubitemid 34211865)
-
(2002)
Gynecologic Oncology
, vol.84
, Issue.3
, pp. 399-403
-
-
McGuire, V.1
Jesser, C.A.2
Whittemore, A.S.3
-
4
-
-
57149093237
-
"BRCAness" syndrome in ovarian cancer: A case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations
-
Tan DS, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S, et al. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol 2008;26:5530-6.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5530-5536
-
-
Tan, D.S.1
Rothermundt, C.2
Thomas, K.3
Bancroft, E.4
Eeles, R.5
Shanley, S.6
-
5
-
-
76049086838
-
Inherited determinants of ovarian cancer survival
-
Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, et al. Inherited determinants of ovarian cancer survival. Clin Cancer Res 2010;16:995-1007.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 995-1007
-
-
Goode, E.L.1
Maurer, M.J.2
Sellers, T.A.3
Phelan, C.M.4
Kalli, K.R.5
Fridley, B.L.6
-
6
-
-
53249109884
-
The effects of common genetic variants in oncogenes on ovarian cancer survival
-
Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, et al. The effects of common genetic variants in oncogenes on ovarian cancer survival. Clin Cancer Res 2008;14:5833-9.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5833-5839
-
-
Quaye, L.1
Gayther, S.A.2
Ramus, S.J.3
Di Cioccio, R.A.4
McGuire, V.5
Hogdall, E.6
-
7
-
-
58149346076
-
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab
-
Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, et al. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 2008;14:7554-63.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7554-7563
-
-
Schultheis, A.M.1
Lurje, G.2
Rhodes, K.E.3
Zhang, W.4
Yang, D.5
Garcia, A.A.6
-
8
-
-
77957584092
-
Common variants at 19p13 are associated with susceptibility to ovarian cancer
-
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010;42:880-4.
-
(2010)
Nat Genet
, vol.42
, pp. 880-884
-
-
Bolton, K.L.1
Tyrer, J.2
Song, H.3
Ramus, S.J.4
Notaridou, M.5
Jones, C.6
-
9
-
-
58149202145
-
Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma
-
Mendiola M, Barriuso J, Redondo A, Marino-Enriquez A, Madero R, Espinosa E, et al. Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma. PLoS One 2008;3:e4051.
-
(2008)
PLoS One
, vol.3
-
-
Mendiola, M.1
Barriuso, J.2
Redondo, A.3
Marino-Enriquez, A.4
Madero, R.5
Espinosa, E.6
-
10
-
-
45549099056
-
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II Consortia
-
Nimeiri HS, Oza AM, Morgan RJ, Friberg G, Kasza K, Faoro L, et al. Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecol Oncol 2008;110:49-55.
-
(2008)
Gynecol Oncol
, vol.110
, pp. 49-55
-
-
Nimeiri, H.S.1
Oza, A.M.2
Morgan, R.J.3
Friberg, G.4
Kasza, K.5
Faoro, L.6
-
11
-
-
74849114007
-
Association of genetic variation in mitotic kinases with breast cancer risk
-
Wang X, Fredericksen ZS, Vierkant RA, Kosel ML, Pankratz VS, Cerhan JR, et al. Association of genetic variation in mitotic kinases with breast cancer risk. Breast Cancer Res Treat 2010;119:453-62.
-
(2010)
Breast Cancer Res Treat
, vol.119
, pp. 453-462
-
-
Wang, X.1
Fredericksen, Z.S.2
Vierkant, R.A.3
Kosel, M.L.4
Pankratz, V.S.5
Cerhan, J.R.6
-
12
-
-
29344462994
-
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer
-
DOI 10.1158/1078-0432.CCR-05-1436
-
Psyrri A, Kassar M, Yu Z, Bamias A, Weinberger PM, Markakis S, et al. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer. Clin Cancer Res 2005;11:8637-43. (Pubitemid 43005911)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.24
, pp. 8637-8643
-
-
Psyrri, A.1
Kassar, M.2
Yu, Z.3
Bamias, A.4
Weinberger, P.M.5
Markakis, S.6
Kowalski, D.7
Camp, R.L.8
Rimm, D.L.9
Dimopoulos, M.A.10
-
13
-
-
2042427915
-
A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging
-
DOI 10.1111/j.1048-891X.2004.014209.x
-
Skirnisdottir I, Seidal T, Sorbe B. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging. Int J Gynecol Cancer 2004;14:259-70. (Pubitemid 38533897)
-
(2004)
International Journal of Gynecological Cancer
, vol.14
, Issue.2
, pp. 259-270
-
-
Skirnisdottir, I.1
Seidal, T.2
Sorbe, B.3
-
14
-
-
20144389741
-
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy
-
DOI 10.1158/1078-0432.CCR-04-1673
-
Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, Gershenson D, et al. Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res 2005;11:2149-55. (Pubitemid 40490171)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.6
, pp. 2149-2155
-
-
Hartmann, L.C.1
Lu, K.H.2
Linette, G.P.3
Cliby, W.A.4
Kalli, K.R.5
Gershenson, D.6
Bast, R.C.7
Stec, J.8
Iartcliouk, N.9
Smith, D.I.10
Ross, J.S.11
Hoersch, S.12
Shridhar, V.13
Lillie, J.14
Kaufmann, S.H.15
Clark, E.A.16
Damokosli, A.I.17
-
15
-
-
37049032569
-
Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: Results from the colon cancer family registry
-
DOI 10.1158/0008-5472.CAN-07-3239
-
Poynter JN, Figueiredo JC, Conti DV, Kennedy K, Gallinger S, Siegmund KD, et al. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res 2007;67:11128-32. (Pubitemid 350248536)
-
(2007)
Cancer Research
, vol.67
, Issue.23
, pp. 11128-11132
-
-
Poynter, J.N.1
Figueiredo, J.C.2
Conti, D.V.3
Kennedy, K.4
Gallinger, S.5
Siegmund, K.D.6
Casey, G.7
Thibodeau, S.N.8
Jenkins, M.A.9
Hopper, J.L.10
Byrnes, G.B.11
Baron, J.A.12
Goode, E.L.13
Tiirikainen, M.14
Lindor, N.15
Grove, J.16
Newcomb, P.17
Jass, J.18
Young, J.19
Potter, J.D.20
Haile, R.W.21
Duggan, D.J.22
Le, M.L.23
more..
-
16
-
-
34247591993
-
Multiple prostate cancer risk variants on 8q24
-
DOI 10.1038/ng0507-579, PII NG0507579
-
Witte JS. Multiple prostate cancer risk variants on 8q24. Nat Genet 2007;39:579-80. (Pubitemid 46676095)
-
(2007)
Nature Genetics
, vol.39
, Issue.5
, pp. 579-580
-
-
Witte, J.S.1
-
17
-
-
46849098205
-
Multiple loci with different cancer specificities within the 8q24 gene desert
-
DOI 10.1093/jnci/djn190
-
Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008;100:962-6. (Pubitemid 351957516)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.13
, pp. 962-966
-
-
Ghoussaini, M.1
Song, H.2
Koessler, T.3
Al, O.A.A.4
Kote-Jarai, Z.5
Driver, K.E.6
Pooley, K.A.7
Ramus, S.J.8
Kjaer, S.K.9
Hogdall, E.10
DiCioccio, R.A.11
Whittemore, A.S.12
Gayther, S.A.13
Giles, G.G.14
Guy, M.15
Edwards, S.M.16
Morrison, J.17
Donovan, J.L.18
Hamdy, F.C.19
Dearnaley, D.P.20
Ardern-Jones, A.T.21
Hall, A.L.22
O'Brien, L.T.23
Gehr-Swain, B.N.24
Wilkinson, R.A.25
Brown, P.M.26
Hopper, J.L.27
Neal, D.E.28
Pharoah, P.D.P.29
Ponder, B.A.J.30
Eeles, R.A.31
Easton, D.F.32
Dunning, A.M.33
more..
-
18
-
-
33746512512
-
Principal components analysis corrects for stratification in genome-wide association studies
-
DOI 10.1038/ng1847, PII NG1847
-
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome- wide association studies. Nat Genet 2006;38:904-9. (Pubitemid 44141658)
-
(2006)
Nature Genetics
, vol.38
, Issue.8
, pp. 904-909
-
-
Price, A.L.1
Patterson, N.J.2
Plenge, R.M.3
Weinblatt, M.E.4
Shadick, N.A.5
Reich, D.6
-
19
-
-
77952517603
-
Risk of ovarian cancer and inherited variants in relapse-associated genes
-
Peedicayil A, Vierkant RA, Hartmann LC, Fridley BL, Fredericksen ZS, White KL, et al. Risk of ovarian cancer and inherited variants in relapse-associated genes. PLoS One 2010;5:e8884.
-
(2010)
PLoS One
, vol.5
-
-
Peedicayil, A.1
Vierkant, R.A.2
Hartmann, L.C.3
Fridley, B.L.4
Fredericksen, Z.S.5
White, K.L.6
-
20
-
-
0033982936
-
KEGG: Kyoto Encyclopedia of Genes and Genomes
-
Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30. (Pubitemid 30047706)
-
(2000)
Nucleic Acids Research
, vol.28
, Issue.1
, pp. 27-30
-
-
Kanehisa, M.1
Goto, S.2
-
21
-
-
77953265316
-
Variation at 8q24 and 9p24 and risk of ovarian cancer
-
White K, Sellers TA, Fridley BL, Vierkant RA, Phelan CM, Schildkraut JM, et al. Variation at 8q24 and 9p24 and risk of ovarian cancer. Twin Res Hum Genet 2010;13:43-56.
-
(2010)
Twin Res Hum Genet
, vol.13
, pp. 43-56
-
-
White, K.1
Sellers, T.A.2
Fridley, B.L.3
Vierkant, R.A.4
Phelan, C.M.5
Schildkraut, J.M.6
-
22
-
-
35348983887
-
A second generation human haplotype map of over 3.1 million SNPs
-
Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL. The International HapMap Consortium, A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-61.
-
(2007)
Nature
, vol.449
, pp. 851-861
-
-
Frazer, K.A.1
Ballinger, D.G.2
Cox, D.R.3
Hinds, D.A.4
Stuve, L.L.5
-
23
-
-
42049104103
-
Genetic variation in the one-carbon transfer pathway and ovarian cancer risk
-
DOI 10.1158/0008-5472.CAN-07-5165
-
Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS, et al. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 2008;68:2498-506. (Pubitemid 351521826)
-
(2008)
Cancer Research
, vol.68
, Issue.7
, pp. 2498-2506
-
-
Kelemen, L.E.1
Sellers, T.A.2
Schildkraut, J.M.3
Cunningham, J.M.4
Vierkant, R.A.5
Pankratz, V.S.6
Fredericksen, Z.S.7
Gadre, M.K.8
Rider, D.N.9
Liebow, M.10
Goode, E.L.11
-
24
-
-
0036275126
-
BeadArray technology: Enabling an accurate, cost-effective approach to high-throughput genotyping
-
Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002;Suppl:56-8, 60-1.
-
(2002)
Biotechniques
, Issue.SUPPL.
-
-
Oliphant, A.1
Barker, D.L.2
Stuelpnagel, J.R.3
Chee, M.S.4
-
25
-
-
13444269543
-
Haploview: Analysis and visualization of LD and haplotype maps
-
DOI 10.1093/bioinformatics/bth457
-
Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
-
(2005)
Bioinformatics
, vol.21
, Issue.2
, pp. 263-265
-
-
Barrett, J.C.1
Fry, B.2
Maller, J.3
Daly, M.J.4
-
26
-
-
0000336139
-
Regression models and life tables (with discussion)
-
Cox DR. Regression models and life tables (with discussion). J R Stat Soc, Ser B . 1972;34:187-220.
-
(1972)
J R Stat Soc, Ser B.
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
28
-
-
0036364293
-
Trend tests for case-control studies of genetic markers: Power, sample size and robustness
-
Freidlin B, Zheng G, Li Z, Gastwirth JL. Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered 2002;53:146-52.
-
(2002)
Hum Hered
, vol.53
, pp. 146-152
-
-
Freidlin, B.1
Zheng, G.2
Li, Z.3
Gastwirth, J.L.4
-
29
-
-
0028030661
-
Statistical analysis of proliferative index data in clinical trials
-
Grambsch P, Louis TA, Bostick RM, Grandits GA, Fosdick L, Darif M, et al. Statistical analysis of proliferative index data in clinical trials. Stat Med 1994;13:1619-34. (Pubitemid 24275841)
-
(1994)
Statistics in Medicine
, vol.13
, Issue.16
, pp. 1619-1634
-
-
Grambsch, P.1
Louis, T.A.2
Bostick, R.M.3
Grandits, G.A.4
Fosdick, L.5
Darif, M.6
Potter, J.D.7
-
30
-
-
34447315844
-
Testing association between disease and multiple SNPs in a candidate gene
-
DOI 10.1002/gepi.20219
-
Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007;31:383-95. (Pubitemid 47051001)
-
(2007)
Genetic Epidemiology
, vol.31
, Issue.5
, pp. 383-395
-
-
Gauderman, W.J.1
Murcray, C.2
Gilliland, F.3
Conti, D.V.4
-
31
-
-
84857105816
-
-
cited Available from
-
The Cancer Genome Atlas (TCGA). [cited 2005]. Available from: http://cancergenome.nih.gov.
-
(2005)
-
-
-
32
-
-
76249090489
-
BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources
-
Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009;10:R130.
-
(2009)
Genome Biol
, vol.10
-
-
Wu, C.1
Orozco, C.2
Boyer, J.3
Leglise, M.4
Goodale, J.5
Batalov, S.6
-
33
-
-
70149113077
-
-
R Foundation for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing
-
R Foundation for Statistical Computing. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
-
(2009)
R: A Language and Environment for Statistical Computing
-
-
-
34
-
-
57149092131
-
Expression and mutational analysis of MET in human solid cancers
-
Ma PC, Tretiakova MS, MacKinnon AC, Ramnath N, Johnson C, Dietrich S, et al. Expression and mutational analysis of MET in human solid cancers. Genes Chromosomes Cancer 2008;47:1025-37.
-
(2008)
Genes Chromosomes Cancer
, vol.47
, pp. 1025-1037
-
-
Ma, P.C.1
Tretiakova, M.S.2
MacKinnon, A.C.3
Ramnath, N.4
Johnson, C.5
Dietrich, S.6
-
35
-
-
27744480858
-
Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer
-
DOI 10.1158/1055-9965.EPI-05-0260
-
Kelemen LE, Sellers TA, Keeney GL, Lingle WL. Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2168-72. (Pubitemid 41603263)
-
(2005)
Cancer Epidemiology Biomarkers and Prevention
, vol.14
, Issue.9
, pp. 2168-2172
-
-
Kelemen, L.E.1
Sellers, T.A.2
Keeney, G.L.3
Lingle, W.L.4
-
37
-
-
53049085702
-
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy
-
Johnatty SE, Beesley J, Paul J, Fereday S, Spurdle AB, Webb PM, et al. ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clin Cancer Res 2008;14:5594-601.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5594-5601
-
-
Johnatty, S.E.1
Beesley, J.2
Paul, J.3
Fereday, S.4
Spurdle, A.B.5
Webb, P.M.6
-
38
-
-
77957575149
-
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"
-
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet 2010;6:e1001016.
-
(2010)
PLoS Genet
, vol.6
-
-
Johnatty, S.E.1
Beesley, J.2
Chen, X.3
Macgregor, S.4
Duffy, D.L.5
Spurdle, A.B.6
-
39
-
-
33847337318
-
A common coding variant in CASP8 is associated with breast cancer risk
-
DOI 10.1038/ng1981, PII NG1981
-
Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007;39:352-8. (Pubitemid 46328496)
-
(2007)
Nature Genetics
, vol.39
, Issue.3
, pp. 352-358
-
-
Cox, A.1
Dunning, A.M.2
Garcia-Closas, M.3
Balasubramanian, S.4
Reed, M.W.R.5
Pooley, K.A.6
Scollen, S.7
Baynes, C.8
Ponder, B.A.J.9
Chanock, S.10
Lissowska, J.11
Brinton, L.12
Peplonska, B.13
Southey, M.C.14
Hopper, J.L.15
McCredie, M.R.E.16
Giles, G.G.17
Fletcher, O.18
Johnson, N.19
Dos, S.S.I.20
Gibson, L.21
Bojesen, S.E.22
Nordestgaard, B.G.23
Axelsson, C.K.24
Torres, D.25
Hamann, U.26
Justenhoven, C.27
Brauch, H.28
Chang-Claude, J.29
Kropp, S.30
Risch, A.31
Wang-Gohrke, S.32
Schurmann, P.33
Bogdanova, N.34
Dork, T.35
Fagerholm, R.36
Aaltonen, K.37
Blomqvist, C.38
Nevanlinna, H.39
Seal, S.40
Renwick, A.41
Stratton, M.R.42
Rahman, N.43
Sangrajrang, S.44
Hughes, D.45
Odefrey, F.46
Brennan, P.47
Spurdle, A.B.48
Chenevix-Trench, G.49
Beesley, J.50
Mannermaa, A.51
Hartikainen, J.52
Kataja, V.53
Kosma, V.-M.54
Couch, F.J.55
Olson, J.E.56
Goode, E.L.57
Broeks, A.58
Schmidt, M.K.59
Hogervorst, F.B.L.60
Veer, L.J.V.61
Kang, D.62
Yoo, K.-Y.63
Noh, D.-Y.64
Ahn, S.-H.65
Wedren, S.66
Hall, P.67
Low, Y.-L.68
Liu, J.69
Milne, R.L.70
Ribas, G.71
Gonzalez-Neira, A.72
Benitez, J.73
Sigurdson, A.J.74
Stredrick, D.L.75
Alexander, B.H.76
Struewing, J.P.77
Pharoah, P.D.P.78
Easton, D.F.79
more..
-
40
-
-
23844512858
-
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses
-
DOI 10.1016/S0140-6736(05)67137-1, PII S0140673605671371
-
Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-59. (Pubitemid 41176017)
-
(2005)
Lancet
, vol.366
, Issue.9486
, pp. 649-659
-
-
Garcia-Closas, M.1
Malats, N.2
Silverman, D.3
Dosemeci, M.4
Kogevinas, M.5
Hein, D.W.6
Tardon, A.7
Serra, C.8
Carrato, A.9
Garcia-Closas, R.10
Lloreta, J.11
Castano-Vinyals, G.12
Yeager, M.13
Welch, R.14
Chanock, S.15
Chatterjee, N.16
Wacholder, S.17
Samanic, C.18
Tora, M.19
Fernandez, F.20
Real, F.X.21
Rothman, N.22
more..
-
41
-
-
77953614989
-
Genetic dissection of intermediate phenotypes as a way to discover novel cancer susceptibility alleles
-
Carvajal-Carmona LG. Genetic dissection of intermediate phenotypes as a way to discover novel cancer susceptibility alleles. Curr Opin Genet Dev 2010;20:308-14.
-
(2010)
Curr Opin Genet Dev
, vol.20
, pp. 308-314
-
-
Carvajal-Carmona, L.G.1
-
42
-
-
33847746580
-
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
-
DOI 10.1158/0008-5472.CAN-06-1147
-
Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR, et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 2007;67:1670-9. (Pubitemid 46383393)
-
(2007)
Cancer Research
, vol.67
, Issue.4
, pp. 1670-1679
-
-
Sawada, K.1
Radjabi, A.R.2
Shinomiya, N.3
Kistner, E.4
Kenny, H.5
Becker, A.R.6
Turkyilmaz, M.A.7
Salgia, R.8
Yamada, S.D.9
Vande, W.G.F.10
Tretiakova, M.S.11
Lengyel, E.12
-
43
-
-
1642417404
-
Hepatocyte Growth Factor Sensitizes Human Ovarian Carcinoma Cell Lines to Paclitaxel and Cisplatin
-
DOI 10.1158/0008-5472.CAN-03-2383
-
Rasola A, Anguissola S, Ferrero N, Gramaglia D, Maffe A, Maggiora P, et al. Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin. Cancer Res 2004;64:1744-50. (Pubitemid 38428697)
-
(2004)
Cancer Research
, vol.64
, Issue.5
, pp. 1744-1750
-
-
Rasola, A.1
Anguissola, S.2
Ferrero, N.3
Gramaglia, D.4
Maffe, A.5
Maggiora, P.6
Comoglio, P.M.7
Di, R.M.F.8
-
44
-
-
33745066065
-
Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cances cells to cisplatin
-
DOI 10.1158/1535-7163.MCT-06-0013
-
Olivero M, Ruggiero T, Saviozzi S, Rasola A, Coltella N, Crispi S, et al. Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin. Mol Cancer Ther 2006;5:1126-35. (Pubitemid 43881304)
-
(2006)
Molecular Cancer Therapeutics
, vol.5
, Issue.5
, pp. 1126-1135
-
-
Oliverro, M.1
Ruggiero, T.2
Saviozzi, S.3
Rasola, A.4
Coltella, N.5
Crispi, S.6
Di, C.F.7
Calogero, R.8
Di, R.M.F.9
-
45
-
-
33646389844
-
P38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis
-
Coltella N, Rasola A, Nano E, Bardella C, Fassetta M, Filigheddu N, et al. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. Int J Cancer 2006;118:2981-90.
-
(2006)
Int J Cancer
, vol.118
, pp. 2981-2990
-
-
Coltella, N.1
Rasola, A.2
Nano, E.3
Bardella, C.4
Fassetta, M.5
Filigheddu, N.6
-
46
-
-
58349112337
-
Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer
-
Permuth-Wey J, Boulware D, Valkov N, Livingston S, Nicosia S, Lee JH, et al. Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer. Cancer Epidemiol Biomarkers Prev 2009;18:28-34.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 28-34
-
-
Permuth-Wey, J.1
Boulware, D.2
Valkov, N.3
Livingston, S.4
Nicosia, S.5
Lee, J.H.6
-
47
-
-
52649085237
-
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
-
Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 2008;14:5198-208.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5198-5208
-
-
Tothill, R.W.1
Tinker, A.V.2
George, J.3
Brown, R.4
Fox, S.B.5
Lade, S.6
-
48
-
-
22544464690
-
Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance
-
DOI 10.1111/j.1525-1438.2005.00117.x
-
Ayhan A, Ertunc D, Tok EC. Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance. Int J Gynecol Cancer 2005;15:618-23. (Pubitemid 41022899)
-
(2005)
International Journal of Gynecological Cancer
, vol.15
, Issue.4
, pp. 618-623
-
-
Ayhan, A.1
Ertunc, D.2
Tok, E.C.3
Ayhan, A.4
-
49
-
-
63549147327
-
Role of genetic polymorphisms and ovarian cancer susceptibility
-
Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F, et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 2009;3:171-81.
-
(2009)
Mol Oncol
, vol.3
, pp. 171-181
-
-
Fasching, P.A.1
Gayther, S.2
Pearce, L.3
Schildkraut, J.M.4
Goode, E.5
Thiel, F.6
-
50
-
-
79955769334
-
Cohorts and consortia conference: A summary report (Banff, Canada, June 17-19, 2009)
-
Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, et al. Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer Causes Control 2011;22:463-8.
-
(2011)
Cancer Causes Control
, vol.22
, pp. 463-468
-
-
Boffetta, P.1
Colditz, G.A.2
Potter, J.D.3
Kolonel, L.4
Robson, P.J.5
Malekzadeh, R.6
|